-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Insulet, Lowers Price Target to $160

Benzinga·08/06/2026 17:30:16
Listen to the news
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $245 to $160.